Coronavirus Update: End Of The Road For Hydroxychloroquine?

Plus Komipharm Pushes Ahead With Panaphix

UK investigators have pulled the plug on the drug trials, saying it is 'useless' in hospitalized COVID-19 patients  - but the WHO is not giving up on its trial just yet.  

Brazil_Hydroxicloroquine
Hydroxychloroquine: hailed as a 'game changer' by President Trump, more and more studies suggest it is ineffective in treating hospitalized COVID-19 patients

Hydroxychloroquine has been shown to be ineffective against COVID-19 in a large randomized trial conducting in the UK, its chief investigators calling on a stop to its use against the novel coronavirus.

The announcement on Friday 5 June by the researchers running the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial came after...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip